Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus.
Zhang H, Zhu X, Li Q, Lou J, Sun J, Shen Z, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Hu Y, Wang J, Chen G, Ding Y, Niu J.
Zhang H, et al. Among authors: li c, li x, li q.
J Pharm Pharmacol. 2018 Jul;70(7):855-864. doi: 10.1111/jphp.12916. Epub 2018 Apr 6.
J Pharm Pharmacol. 2018.
PMID: 29630721
Clinical Trial.